• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结核性胸腔积液诊断的评分模型。

A scoring model for diagnosis of tuberculous pleural effusion.

机构信息

Department of Respiratory and Critical Care Medicine, Dongguan People's Hospital, 78 Wandao Road South, Dongguan, 523059, Guangdong, China.

Department of Pathophysiology, Key Laboratory of State Administration of Traditional Chinese Medicine of the People's Republic of China, School of Medicine, Jinan University, Guangzhou, 510632, Guangdong, China.

出版信息

BMC Pulm Med. 2022 Sep 2;22(1):332. doi: 10.1186/s12890-022-02131-7.

DOI:10.1186/s12890-022-02131-7
PMID:36056429
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9438342/
Abstract

BACKGROUND

Due to the low efficiency of a single clinical feature or laboratory variable in the diagnosis of tuberculous pleural effusion (TBPE), the diagnosis of TBPE is still challenging. This study aimed to build a scoring diagnostic model based on laboratory variables and clinical features to differentiate TBPE from non-tuberculous pleural effusion (non-TBPE).

METHODS

A retrospective study of 125 patients (63 with TBPE; 62 with non-TBPE) was undertaken. Univariate analysis was used to select the laboratory and clinical variables relevant to the model composition. The statistically different variables were selected to undergo binary logistic regression. Variables B coefficients were used to define a numerical score to calculate a scoring model. A receiver operating characteristic (ROC) curve was used to calculate the best cut-off value and evaluate the performance of the model. Finally, we add a validation cohort to verify the model.

RESULTS

Six variables were selected in the scoring model: Age ≤ 46 years old (4.96 points), Male (2.44 points), No cancer (3.19 points), Positive T-cell Spot (T-SPOT) results (4.69 points), Adenosine Deaminase (ADA) ≥ 24.5U/L (2.48 point), C-reactive Protein (CRP) ≥ 52.8 mg/L (1.84 points). With a cut-off value of a total score of 11.038 points, the scoring model's sensitivity, specificity, and accuracy were 93.7%, 96.8%, and 99.2%, respectively. And the validation cohort confirms the model with the sensitivity, specificity, and accuracy of 92.9%, 93.3%, and 93.1%, respectively.

CONCLUSION

The scoring model can be used in differentiating TBPE from non-TBPE.

摘要

背景

由于单个临床特征或实验室变量在结核性胸腔积液(TBPE)诊断中的效率较低,因此 TBPE 的诊断仍然具有挑战性。本研究旨在建立基于实验室变量和临床特征的评分诊断模型,以区分 TBPE 和非结核性胸腔积液(non-TBPE)。

方法

对 125 例患者(63 例 TBPE;62 例 non-TBPE)进行回顾性研究。采用单因素分析筛选与模型组成相关的实验室和临床变量。对统计学差异的变量进行二项逻辑回归分析。变量 B 系数用于定义数值评分以计算评分模型。采用受试者工作特征(ROC)曲线计算最佳截断值并评估模型性能。最后,我们添加验证队列来验证模型。

结果

评分模型中选择了 6 个变量:年龄≤46 岁(4.96 分)、男性(2.44 分)、无癌症(3.19 分)、T 细胞斑点(T-SPOT)阳性结果(4.69 分)、腺苷脱氨酶(ADA)≥24.5U/L(2.48 分)、C 反应蛋白(CRP)≥52.8mg/L(1.84 分)。总评分的截断值为 11.038 分,评分模型的敏感性、特异性和准确性分别为 93.7%、96.8%和 99.2%。验证队列证实该模型的敏感性、特异性和准确性分别为 92.9%、93.3%和 93.1%。

结论

评分模型可用于区分 TBPE 和 non-TBPE。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24c4/9438342/829f95f23e01/12890_2022_2131_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24c4/9438342/ab170232e76f/12890_2022_2131_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24c4/9438342/829f95f23e01/12890_2022_2131_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24c4/9438342/ab170232e76f/12890_2022_2131_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24c4/9438342/829f95f23e01/12890_2022_2131_Fig2_HTML.jpg

相似文献

1
A scoring model for diagnosis of tuberculous pleural effusion.结核性胸腔积液诊断的评分模型。
BMC Pulm Med. 2022 Sep 2;22(1):332. doi: 10.1186/s12890-022-02131-7.
2
[A scoring model for a differential diagnosis of tuberculous and non-tuberculous pleurisy].[一种用于鉴别结核性胸膜炎和非结核性胸膜炎的评分模型]
Zhonghua Yi Xue Za Zhi. 2011 Sep 13;91(34):2392-6.
3
Clinical characteristics and potential indicators for definite diagnosis of tuberculous pleural effusion.结核性胸腔积液的临床特征及明确诊断的潜在指标。
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):1924-1931. doi: 10.1080/21691401.2019.1613417.
4
Differentiating between tuberculous and non-tuberculous pleural effusions using the pleural fluid ratio of 10× adenosine deaminase/lactate dehydrogenase.利用胸腔积液中10倍腺苷脱氨酶与乳酸脱氢酶的比值鉴别结核性和非结核性胸腔积液。
J Thorac Dis. 2023 May 30;15(5):2627-2635. doi: 10.21037/jtd-23-383. Epub 2023 May 29.
5
Interleukin 27 could be useful in the diagnosis of tuberculous pleural effusions.白细胞介素 27 可能有助于结核性胸腔积液的诊断。
Respir Care. 2014 Mar;59(3):399-405. doi: 10.4187/respcare.02749. Epub 2013 Aug 20.
6
Use of T-SPOT.TB for the diagnosis of unconventional pleural tuberculosis is superior to ADA in high prevalence areas: a prospective analysis of 601 cases.T-SPOT.TB 在高发地区用于诊断非典型性胸腔结核优于 ADA:一项 601 例前瞻性分析。
BMC Infect Dis. 2021 Jan 4;21(1):4. doi: 10.1186/s12879-020-05676-2.
7
Optimising the utility of pleural fluid adenosine deaminase for the diagnosis of adult tuberculous pleural effusion in Hong Kong.优化胸腔积液腺苷脱氨酶在香港成人结核性胸腔积液诊断中的应用价值。
Hong Kong Med J. 2018 Feb;24(1):38-47. doi: 10.12809/hkmj176238. Epub 2017 Dec 22.
8
Development and Validation of the COMPLES Score for Differentiating Between Tuberculous Effusions with Low Pleural pH or Glucose and Complicated Parapneumonic Effusions.用于鉴别低胸膜pH值或葡萄糖的结核性胸腔积液与复杂性类肺炎性胸腔积液的COMPLES评分的开发与验证
Lung. 2016 Oct;194(5):847-54. doi: 10.1007/s00408-016-9923-y. Epub 2016 Jul 11.
9
Procalcitonin as a diagnostic marker in differentiating parapneumonic effusion from tuberculous pleurisy or malignant effusion.降钙素原作为鉴别脓胸性胸腔积液与结核性胸膜炎或恶性胸腔积液的诊断标志物。
Clin Biochem. 2013 Oct;46(15):1484-8. doi: 10.1016/j.clinbiochem.2013.03.018. Epub 2013 Apr 6.
10
Differentiating tuberculous from malignant pleural effusions: a scoring model.鉴别结核性与恶性胸腔积液:一种评分模型。
Med Sci Monit. 2003 May;9(5):CR175-80.

引用本文的文献

1
Development and validation of a prediction model based on a nomogram for tuberculous pleural effusion.基于列线图的结核性胸腔积液预测模型的开发与验证
Front Med (Lausanne). 2025 Jul 18;12:1589406. doi: 10.3389/fmed.2025.1589406. eCollection 2025.

本文引用的文献

1
Differentiating tuberculous pleuritis from other exudative lymphocytic pleural effusions.鉴别结核性胸膜炎与其他渗出性淋巴细胞性胸腔积液。
Ann Palliat Med. 2020 Sep;9(5):2508-2515. doi: 10.21037/apm-19-394. Epub 2020 Aug 27.
2
Diagnostic utility of pleural fluid T-SPOT and interferon-gamma for tuberculous pleurisy: A two-center prospective cohort study in China.胸腔积液 T-SPOT 和干扰素-γ对结核性胸膜炎的诊断价值:中国两中心前瞻性队列研究。
Int J Infect Dis. 2020 Oct;99:515-521. doi: 10.1016/j.ijid.2020.08.007. Epub 2020 Aug 7.
3
The diagnostic utility of pleural markers for tuberculosis pleural effusion.
胸膜标志物对结核性胸腔积液的诊断价值。
Ann Transl Med. 2020 May;8(9):607. doi: 10.21037/atm.2019.09.110.
4
WHO global progress report on tuberculosis elimination.世界卫生组织结核病消除全球进展报告。
Lancet Respir Med. 2020 Jan;8(1):19. doi: 10.1016/S2213-2600(19)30418-7. Epub 2019 Nov 6.
5
Identifying tuberculous pleural effusion using artificial intelligence machine learning algorithms.利用人工智能机器学习算法识别结核性胸腔积液。
Respir Res. 2019 Oct 16;20(1):220. doi: 10.1186/s12931-019-1197-5.
6
Epidemiology of Extrapulmonary Tuberculosis among Inpatients, China, 2008-2017.2008-2017 年中国住院患者肺外结核病流行病学。
Emerg Infect Dis. 2019 Mar;25(3):457-464. doi: 10.3201/eid2503.180572.
7
Epidemiology and diagnosis of pleural tuberculosis in a low incidence country with high rate of immigrant population: A retrospective study.低发病率国家中具有高移民人口的胸膜结核的流行病学和诊断:一项回顾性研究。
Int J Infect Dis. 2019 Jan;78:34-38. doi: 10.1016/j.ijid.2018.10.005. Epub 2018 Oct 25.
8
Global Epidemiology of Tuberculosis.全球结核病流行病学。
Semin Respir Crit Care Med. 2018 Jun;39(3):271-285. doi: 10.1055/s-0038-1651492. Epub 2018 Aug 2.
9
Early diagnosis of tuberculous pleural effusion: apart from pleural fluid adenosine deaminase, pleural biopsy still has a role.结核性胸腔积液的早期诊断:除了胸水腺苷脱氨酶外,胸膜活检仍有作用。
Hong Kong Med J. 2018 Jun;24(3):316-317. doi: 10.12809/hkmj187289.
10
Tuberculous pleural effusion.结核性胸腔积液
J Thorac Dis. 2016 Jul;8(7):E486-94. doi: 10.21037/jtd.2016.05.87.